Spectrum Pharmaceuticals...
Published (2009-11-30 07:21:51)
Spectrum Pharmaceuticals Announces Completion of Enrollment in One Apaziquone Phase 3 Pivotal Trial for Bladder Cancer Ahead ... Date : 11/30/2009 @ 7:00AM Source : Business Wire Stock : Spectrum Pharmaceuticals (SPPI) Quote : 4.43 -0.24 (-5.14%) @ 7:22AM Spectrum Pharmaceuticals Announces Completion of Enrollment in One Apaziquone Phase 3 Pivotal Trial for Bladder Cancer Ahead ... Spectrum Pharmaceuticals (NasdaqGM: SPPI) today announced that...